amyris inc amrso company profile  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states profile amyris inc amrso related topics stocksstock screenerbasic materialsspecialty chemicals overview news key developments people charts financials analysts research pulse amrso on nasdaq usd am edt change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  full description amyris inc incorporated on april   is an integrated industrial biotechnology company the company is engaged in research and development and sales of fuels and farnesenederived products the company is applying its industrial synthetic biology platform to engineer manufacture and sell products into a range of consumer and industrial markets including cosmetics flavors and fragrances ff solvents and cleaners polymers lubricants healthcare products and fuels the company intends to apply its technology to the development of pharmaceutical products the company focuses on a renewable hydrocarbon molecule called farnesene biofene which forms the basis for a range of products including emollients flavors and fragrance oils and diesel fuel the companys subsidiaries are amyris brasil ltda and amyris fuels llcthe company is producing approximately four molecules at its industrial fermentation plant artemisinic acid farnesene and over two fragrance molecules the company is expanding its range of products across various categories divided into consumer and industrial applications for consumer applications the company is developing and selling personal care products which include ingredients for cosmetics and ff healthcare products and formulated end user products such as biossance brand skincare products and muck daddy brand hand cleaner product it is pursuing arrangements with a number of drug companies for their use of its molecules to develop pharmaceutical products for industrial applications the companys products include performance materials such as solvents and polymers and with its joint venture partners renewable lubricants and fuels its initial portfolio of commercial products has been based on biofene and biofene derivatives in addition it has produced at scale and commercialized over two target molecules for the ff market the company markets its solvent product under the myralene brand the company is developing applications for its farnesene that include highperformance polymers used in tires and other applications using farnesene the company produces renewable diesel a farnesene derivative referred to as farnesane and jet fuel » full overview of amrso company address amyris inc  hollis st ste emeryville   ca    p f  company web links home page officers  directors name compensation john melo  kathleen valiasek  joel cherry  karen rohde  chris jaenike  » more officers  directors amyris inc news briefamyris says second tranche of  mln in a private placement days is being led by a mln investment from koninklijke​ am edt briefamyris enters into first product development production agreement with royal dsm jul   briefamyris on june   company issued sold an amended restated note in principal amount of  mln to purchaser jul   briefamyris and government of queensland announced plans to develop a industrial biotechnology hub in southeast asia jun   briefamyris announces reverse stock split jun   » more amrso news related topics stocksstock screenerbasic materialsspecialty chemicals amyris inc nasdaqamrs quotes  news  google financemy accountsearchmapsyoutubeplaygmaildrivecalendargoogletranslatephotosmoredocsbloggercontactshangoutskeepeven more from googlesign inhidden fieldssearch financeadobe flash player is required for interactive charts allowfinancemore resultsamyris incnasdaqamrsadd to portfoliocompanysummarynewsrelated companieshistorical pricesfinancialsmarketsnewsportfoliosstock screenergoogle domestic trendsrecent quotes  daysyou have no recent quoteschg   amyris inc  public nasdaqamrs   watch this stock   find more results for amrs    realtime   am edt nasdaq realtime data  disclaimer currency in usd range     week    open  vol  avg  mkt cap m pe      divyield      eps  shares m beta  inst own  news relevance date all news for amyris inc » subscribe advertisement events add amrs to my calendars aug   q  amyris inc earnings call  pm edt  aug   q  amyris inc earnings release  pm edt  jul   amyris inc extraordinary shareholders meeting may   amyris inc at cowen technology media  telecom conference may   amyris inc annual shareholders meeting may   amyris inc corporate analyst meeting  may   q  amyris inc earnings call  may   q  amyris inc earnings release more events from dailyfinance »     key stats and ratios q mar   net profit margin   operating margin   ebitd margin   return on average assets   return on average equity   employees   cdp score   address  hollis st ste emeryville ca united states  map phone fax website links httpsamyriscom external links analyst estimates  marketwatch sec filings  edgar online major holders  msn money research reports  reuters settings  technicals  link to this view volume delayed by  minsprices are not from all markets sources include six advertisement related companies show most recent quarter most recent annual add or remove columns save changes cancel sector basic materials  industry industrial biotechnology chemicals more from factset » description amyris inc is an integrated industrial biotechnology company the company is engaged in research and development and sales of fuels and farnesenederived products it is applying its industrial synthetic biology platform to engineer manufacture and sell products into a range of consumer and industrial markets including cosmetics flavors and fragrances ff solvents and cleaners polymers lubricants healthcare products and fuels the company focuses on a renewable hydrocarbon molecule called farnesene biofene the company is expanding its range of products across various categories divided into consumer and industrial applications for consumer applications the company is developing and selling personal care products which include ingredients for cosmetics and ff healthcare products and formulated end user products such as biossance brand skincare products and muck daddy brand hand cleaner product more from reuters » officers and directors john g melo president chief executive officer director age  bio  compensation   reuters kathleen valiasek chief financial officer bio  compensation   reuters joel cherry phd president  research and development age  bio  compensation   reuters karen d rohde chief human resources officer bio  compensation   reuters chris jaenike interim general counsel bio  compensation   reuters philip eykerman director age  bio  compensation   reuters abraham klaeijsen director bio  compensation   reuters christophe vuillez director bio  compensation   reuters patrick y yang director age  bio  compensation   reuters abdullah bin khalifa al thani independent director age  bio  compensation   reuters full list on reuters » google finance beta available in hong kong  canada  us  china  ukinformation is provided as is and solely for informational purposes not for trading purposes or advice and may be delayedto see all exchange delays please see disclaimer google  google home  blog  help  report a problem  privacy policy  terms of service amyris company  wikipedia amyris company from wikipedia the free encyclopedia jump to navigation search this article needs additional citations for verification please help improve this article by adding citations to reliable sources unsourced material may be challenged and removed november  learn how and when to remove this template message amyris inc type public nasdaq amrs industry renewable fuels antimalaria renewable chemicals renewable products founded  headquarters emeryville california usa key people john melo ceo revenue none number of employees    website amyriscom amyris is an integrated renewable products company providing sustainable alternatives to a broad range of petroleumsourced products and rare materials amyris in conjunction with various partners is creating industrial scale supplies of vitamins captive perfume molecules like ambroxan a patchouli substitute and farnesene which can be used in tires and lubricant as well as their own beauty care product line using squalane their substitute molecule for shark oil amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules flexible building blocks which can be used in a wide range of products they do this by reengineering yeast so it can recreate complicated molecules the time to market was reduced four fold after amyris teamed with darpa amyris is commercializing these products both as renewable ingredients in cosmetics flavors fragrances polymers lubricants and consumer products and also as renewable diesel and jet fuels amyris brasil sa a subsidiary of amyris oversees the establishment and expansion of amyris’s production in brazil amyris also has fuel distribution capabilities in the united states through its subsidiary amyris fuels llc founded in  and headquartered in emeryville ca amyris has raised over  million in equity funding todate including investments from royal dsm total sa khosla ventures votorantim novos negócios kleiner perkins caufield  byers tpg biotech and dag ventures as well as darpa amyris is opening two more plants in new zealand and korea in proximity to sustainable sugar cane crops the company went public on nasdaq in october  amrs but as of january  was trading at less than  of its initial offering price due to lack of commercial success in costeffectively producing drop in synthetic transportation fuel which was to be its initial major focus the firm has now focused its attention on higherpriced and highermargin products that are not in the transportation fuel area  contents  renewable fuels  artemisinin  media coverage  references  external links renewable fuelsedit amyris technology platform branded no compromise is focused on providing high performance petroleumalternatives using sustainable feedstock such as sugarcane amyris is establishing the partnerships and capabilities needed to bring the renewable diesel fuel to market a few of these actions include distributing ethanol through a us subsidiary amyris fuels based in chicago il building a large scale production facility at sao martino one of brazils largest ethanol producers joint venture with cosan one of brazils largest ethanol distributors and marketers artemisininedit artemisinin is a compound naturally found in the chinese sweet wormwood plant effective in the treatment of malaria its production is hampered by difficult climate and agricultural conditions institute for oneworld health received a grant from the bill and melinda gates foundation to develop and produce nonseasonal highquality affordable artemisinin and engaged amyris biotechnologies and sanofi to assist on certain parts of the project which is near completion based on technology from uc berkeley nrc canada and other sources media coverageedit using microbes to create the next generation of fuels on cnn the next list february  a better biofuel on mit technology review april  bets on biotech on us news november  referencesedit  fast company magazine  august  the rise and fall of the company that was going to have us all using biofuels external linksedit official website retrieved from httpsenwikipediaorgwindexphptitleamyriscompanyoldid categories companies based in emeryville californiabiotechnology companies of the united statesbiotechnology companies established in companies listed on nasdaq establishments in californiaamerican companies established in hidden categories articles needing additional references from november all articles needing additional referencespages using deprecated image syntax navigation menu personal tools not logged intalkcontributionscreate accountlog in namespaces article talk variants views read edit view history more search navigation main pagecontentsfeatured contentcurrent eventsrandom articledonate to wikipediawikipedia store interaction helpabout wikipediacommunity portalrecent changescontact page tools what links hererelated changesupload filespecial pagespermanent linkpage informationwikidata itemcite this page printexport create a bookdownload as pdfprintable version languages add links this page was last edited on  july  at  text is available under the creative commons attributionsharealike license additional terms may apply by using this site you agree to the terms of use and privacy policy wikipedia® is a registered trademark of the wikimedia foundation inc a nonprofit organization privacy policy about wikipedia disclaimers contact wikipedia developers cookie statement mobile view amyris inc amrso key developments  reuterscom x edition united states africa américa latina عربي argentina brasil canada  deutschland españa france india italia  méxico россия united kingdom united states amyris inc amrso related topics stocksstock screenermarket databasic materialsspecialty chemicals overview news key developments people charts financials analysts research pulse amrso on nasdaq usd  aug  change  chg   prev close  open  days high  days low  volume  avg vol  wk high  wk low  latest key developments source significant developments biossance says will expand to sephora in over  sephora locations across canada wednesday  jul  am edt  july  reuters  amyris inc biossance says will expand to sephora in over  sephora locations across canada in january   full article amyris enters into first product development production agreement with royal dsm monday  jul  am edt  july  reuters  amyris inc amyris enters into first product development and production agreement with royal dsm for food and nutrition moleculeamyris inc  ‍as part of agreement dsm will partner with co fund development of technology to produce specific molecule that co will scale supply​  full article amyris on june   company issued sold an amended restated note in principal amount of  mln to purchaser friday  jul  pm edt  july  reuters  amyris inc amyris inc  on june   company issued and sold an amended and restated note in principal amount of  million to purchaser  sec filingamyris inc  in connection with issuance and sale of  million note company and purchaser entered into a letter agreementamyris inc  pursuant to letter agreement purchaser has right to cause coto redeem all of outstanding principal amount of  million note in cashamyris inc  pursuant to letter agreement purchaser has right to cause company to redeem all of outstanding principal amount of  million note in cash  full article amyris and government of queensland announced plans to develop a industrial biotechnology hub in southeast asia tuesday  jun  am edt  june  reuters  amyris inc amyris inc and government of queensland australia announced plans to develop a industrial biotechnology hub in southeast asia  full article amyris announces reverse stock split tuesday  jun  am edt  june  reuters  amyris inc amyris announces reverse stock split  delivering on strong product revenue growth and executionamyris inc every  presplit shares of common stock held by stockholders will automatically be converted into one share of common stockamyris inc  cos common stock will begin trading on a splitadjusted basis as of commencement of trading on june    full article amyris reports q loss per share of  monday  may  pm edt  may  reuters  amyris inc amyris reports  pct product revenue growth over prior year  continued strong outlookq loss per share q revenue rose  percent to  millionq revenue view  million  thomson reuters ibesq earnings per share view   thomson reuters ibesexpect to deliver around  million of product revenue for significant progress in healthy sweeteners with expected commercial production in  of low costsees fy total revenue to be better than  planexpects growing farnesene for vitamin e oil from around  million in  to around  million in expect to deliver around  million of product revenue for  or more than double from   full article dsm to make equity investment in amyris monday  may  am edt  may  reuters  dsm royal dsm to make equity investment in amyris  with the purpose of establishing a longterm relationshipagreed to make an initial equity investment in amyris of us million translating into a shareholding of about  pctsubject to the satisfaction of certain conditions dsm may invest an additional us million in amyrisfirst tranche is expected to close on may   with second tranche if approved by dsm’s managing board expected to close within  days of closing of first tranche  full article amyris says entered into securities purchase agreement with certain investors monday  may  am edt  may  reuters  amyris inc amyris inc  on may   amyris inc entered into a securities purchase agreement with certain investors  sec filingamyris inc expects net proceeds from sale of securities to be about  millionamyris inc  intends to use about  million of net proceeds from offering for redemption of convertible notes issued by co in dec  and april amyris inc says to sell  shares of cos s series a  convertible preferred stock about  shares of cos series b  convertible preferred stock  full article amyris announces agreements for up to  mln in equity financing monday  may  am edt  may  reuters  amyris inc amyris announces agreements for up to  million in equity financing and inprocess initiative to significantly reduce debtequity financing commitment includes participation by koninklijke dsm nv dsm agreed to initial equity investment in co of  millionsubject to satisfaction of certain conditions dsm may invest an additional  million in amyrisis in process of reducing its debt by about  million about  million of such amount is being converted pursuant to terms of equity financing  full article amyris makes develomental progress in its healthy sweetener product technology monday  may  am edt  may  reuters  amyris inc amyris inc  made significant progress in development of its healthy sweetener product technology and expects industrial production to occur in expects sweetener product opportunity in partnership with its partner to deliver over  million in annual revenue by   full article previous next amyris inc news briefamyris enters into first product development production agreement with royal dsm  amyris enters into first product development and production agreement with royal dsm for food and nutrition molecule » more amrso news earnings vs estimates » more financials related topics stocksstock screenermarket databasic materialsspecialty chemicals management  amyris      about our story management board of directors innovate with us products health  nutrition personal care industrial news press releases blog investors overview press releases corporate governance corporate presentation financial information stock information careers contact us amyris delivers highperformance alternatives to petroleum plant and animalbased products across a wide range of consumer and industry segments our products offer customers a way to reduce environmental impact with no compromise® in performance or availability we are making better chemistry biologically corporate presentation snapshot investor faqs printed materials contact us management board of directors committee composition press releases events  presentations sec filings annual reports and proxies quarterly results key ratios stock information historic stock lookup investment calculator analyst coverage management show all john melo president  chief executive officer with amyris since  john melo has  years of combined experience as an entrepreneur and thought leader in developing and growing technology companies and as a senior executive in the oil  gas industry as president and chief executive officer mr melo has led amyris through successful technology development industrial start up product development and commercialization and a series of funding rounds including the initial public offering before joining amyris in  mr melo served in various senior executive positions at bp plc formerly british petroleum most recently as president of us fuels operations where he successfully led a business transformation and significantly improved the financial performance during his tenure at bp mr melo also served as chief information officer of the refining and marketing segment senior advisor for ebusiness strategy to lord browne bp group chief executive and director of global brand development in this last role he helped develop the “helios” rebranding effort before joining bp mr melo was with ernst  young mr melo currently serves on the board of directors of renmatix inc serves on the board of directors of baybio serves on the bio industrial and environmental section governing board is a member of the council for the portuguese diaspora and is a member of young presidents’ organization ypo he was formerly an appointed member to the us section of the usbrazil ceo forum when not working on the mission of making sustainable chemistry mainstream or championing the eradication of malaria john enjoys skiing reading and time with his family on the island of pico in the azores his childhood home download photo holdings  shares view transactions recent stock transactions by john melo date type shares traded price range may   disposition non open market   apr   disposition non open market   nov   disposition non open market   jun   sell   jun   disposition non open market   may   acquisition non open market  na apr   disposition non open market   nov   acquisition non open market  na jun   acquisition non open market  na jun   automatic sell   jun   automatic sell   jun   automatic sell   may   automatic sell   may   automatic sell   may   automatic sell   apr   disposition non open market   may   sell   may   acquisition non open market  na apr   disposition non open market   jan   disposition non open market   jun   acquisition non open market  na may   sell   apr   disposition non open market   jan   disposition non open market   aug   sell   aug   sell   aug   option execute   aug   option execute   may   acquisition non open market   apr   acquisition non open market  na jan   disposition non open market   oct   automatic sell   oct   option execute   aug   automatic sell     aug   option execute   aug   automatic sell     aug   option execute   aug   automatic sell     aug   option execute   jul   automatic sell   jul   option execute   jul   automatic sell   jul   option execute   jul   automatic sell   jul   option execute   jul   automatic sell   jul   option execute   jul   automatic sell   jul   option execute   jun   automatic sell   kathleen valiasek chief financial officer kathleen valiasek joined amyris as chief financial officer in january  her resultsdriven background includes specific areas of expertise in finance strategic planning debt and equity financing business development and mergers and acquisitions prior to joining amyris valiasek was founder and chief executive officer of lenox group inc a finance and strategic consulting firm where she worked closely with the senior management teams of fastgrowing companies including startups venturebacked and fortune  companies  she has deep experience across diverse industries including life sciences tech retail telecommunications and healthcare prior to her role at lenox group she served in key venture capital real estate development and accounting roles valiasek holds a bachelor of business administration degree in accounting from the university of massachusetts amherst christine ofori chief human resources officer as amyris chief human resources officer christine ofori is responsible for leading and integrating all facets of amyris’s hr goals including people strategy and enhancement of company culture in order to deliver and enable business growth  christine brings many years of hr leadership experience to amyris including successful integration of people technologies processes and cultures  most recently christine served as vice president of human resources at amyris where she guided all aspects of employee development staffing and business partnering  prior to that she spent over eight years with equinix inc as senior director human resources supporting the americas region  christine studied business at the university of minnesota   download photo joel cherry phd president research  development with amyris since  joel cherry leads amyris research and development including various ongoing collaborations prior to joining amyris dr cherry was senior director of bioenergy biotechnology at novozymes during his tenure at novozymes he was a member of the rd management team specializing in protein engineering and directed evolution technologies he was also principal investigator and director of the bioenergy project an effort funded by the us department of energy to reduce the cost of enzymes used in converting biomass to sugar this work was awarded an rd  award scientific american top  award and a frost and sullivan emerging technology award dr cherry is an inventor on more than  issued patents author of three book chapters and more than  scientific publications and an invited speaker at numerous international conferences on biofuels he received his ba from carleton college in chemistry a ph d in biochemistry from the university of new hampshire download photo holdings  shares view transactions recent stock transactions by joel cherry phd date type shares traded price range may   acquisition non open market  na may   disposition non open market   apr   disposition non open market   nov   disposition non open market   jun   disposition non open market   may   acquisition non open market  na apr   disposition non open market   nov   acquisition non open market  na jun   acquisition non open market  na apr   disposition non open market   may   acquisition non open market  na apr   disposition non open market   jan   disposition non open market   jun   acquisition non open market  na apr   disposition non open market   may   acquisition non open market   apr   acquisition non open market  na jan   disposition non open market   jan   disposition non open market   sep   automatic sell   sep   option execute   aug   automatic sell   aug   option execute   aug   automatic sell   aug   option execute   aug   automatic sell   aug   option execute   jun   automatic sell     jun   option execute   jun   automatic sell   jun   option execute   jun   automatic sell   jun   option execute   may   automatic sell   may   option execute   may   automatic sell     may   option execute   may   automatic sell   may   option execute   apr   acquisition non open market  na mar   automatic sell   mar   option execute   mar   automatic sell   mar   option execute   cynthia bryant senior vice president corporate development  collaborations cynthia bryant leads amyriss corporate development and collaborations efforts she joined the company in june  as senior vice president corporate development and collaborations and prior to joining amyris she served as senior director marketing and business development for novozymes denmark where she developed and managed the companys global household care business bryant had pl responsibility for this global business unit that represents approximately a third of novozymes overall business previously her roles at novozymes usa included senior director global biomass business development where she was responsible for growing the companys global cellulosic ethanol business and as global marketing manager – biofuels where she was responsible for strategy development execution and public relations before joining novozymes bryant worked as marketing manager for chevron corporations retail downstream business she has also held product management and operational and engineering roles with other companies such as assyst gmbh germanyusa and burlington industries inc bryant holds a masters in business administration from university of california berkeley as well as a bachelor of science degree in textile engineering from north carolina state university download photo caroline hadfield senior vice president personal care caroline hadfield joined amyris in june  as senior vice president personal care and leads the companys bb and bc sales initiatives for its consumer cosmetic products previously hadfield owned and operated an established retail consultancy practice specializing in the health wellness and the personal care market sectors prior to that she cofounded luxury spa interests in the united kingdom and san francisco where she developed branded spa products and also served as global product director for bodyshop international where she was responsible for a complete range of globally sourced and regionally targeted products and contributed extensively to marketing strategy and packaging design before joining bodyshop hadfield was senior vice president at sephora part of lvmh group and was part of the executive team that rolled out the sephora concept across the us opening  stores within just  months her experience also includes prior roles in merchandizing as svp – general merchandise manager with duty free shoppers part of lvmh and as buying controller with burton group now arcadia hadfield holds a bachelor of arts honours degree in textiles and management from leeds university and has completed a senior executive program at stanford university download photo jim iacoponi senior vice president industrial products jim iacoponi joined amyris in  and is responsible for all farnesene and derivatives sales to industrial customers across the fuels lubricants polymers synthetic rubber and solvents markets additionally he leads the supply chain regulatory and coproduct teams for the company iacoponi has over three decades of diverse experience in the downstream energy business prior to joining amyris he was vice president of operations for propel fuels building california’s leading renewable fuel retail network providing flex fuel and renewable diesel to consumers previously he served at bp plc for  years where he held numerous leadership roles including in convenience retailing petroleum refining sales operations strategy development business restructuring and supply chain management jim has extensive customerfacing background in bb and bc channels as well as in global specialty chemical sales he led bp’s companyoperated and dealer business  locations  employees east of the rockies and bp’s transition in the us to a franchiseeowned and operated business he has held senior finance positions in manufacturing and led bp’s planning forecasting and performance management activity for its global retail business he holds a bachelor of science in civil engineering from the university of notre dame and a master of science in management from purdue university charles kraft senior vice president global manufacturing  process development with amyris since  chuck kraft leads amyriss global manufacturing and process development operations mr kraft has three decades of experience in specialty fermentation prior to joining amyris he was vice president of operations and earlier vice president of engineering at dupont tate and lyle bioproducts a joint venture producing  propanediol biopdo™ via fermentation of plantbased sugars previously for nearly two decades he held a number of operational positions at tate  lyles citric acid production facility in the united states he holds mba and bs degrees from the university of dayton ohio   download photo stock transaction information provided by edgar online amyris makes no representation or warranty with respect to any of the information contained herein takes no responsibility for supplementing updating or correcting any such information and shall have no liability with respect to any such information this listing does not include derivatives such as stock option grants or shares purchased through an employee stock purchase plan for recent transactions including derivative transactions see our section  sec filings page briefcase briefcase printed materials printed materials email alerts email alerts snapshot snapshot rss rss print print email email share share facebook google linkedin twitter email rss stay up to date sign up about our story management board of directors innovate with us products health  nutrition personal care industrial news press releases blog investors overview press releases corporate governance corporate presentation financial information stock information careers contact us recent tweets   copyright amyris  all rights reserved     privacy policy amyris inc    facebook facebook？      hollis st wwwamyriscom ·   berkeley biolabsbiocuriousbiobuilderbiotechnology （）amyris inc · english us · español · português brasil · français france ·  ·  · ad choices · cookie ·  facebook   ben yuan · as per previous employees poor management just painting good pictures getting paid a lot for burning money fast totally destroyed the company lost  of the value plus massive debt the revenue is even not enough pay for directorss salaryoluwarantimifunrere akindeleakinniyi · amyris is an innovative company with great result in anything it doesthis is an amazing establishment that raise hopebdoe future technology and human and environment safetysteve salter · sounds like farnesene is a strong canidate to change everythinghyeok hahntrue hydrocarbon biofuels nobody can match that haamyris darpa living foundries projectamyris inc ·   · amyris announces agreements for  million in second tranche of equity financing exceeding previous target of  million httpbitlywojkgbamyris announces agreements for  million in second tranche of equity financing exceeding previous target of  millionemeryville calif aug   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced agreements for  million in equity financing as part of the second tranche of its previously annouinvestorsamyriscomamyris inc ·   · amyris to announce second quarter  financial results on thursday august   httpbitlyvpxlamyris to announce second quarter  financial results on thursday august  emeryville calif aug   globe newswire  amyris inc nasdaqamrs will report financial results for the second quarter ended june   after market close on thursday august   the company winvestorsamyriscomamyris inc ·   · amyris biossance launches in sephora canada stores httpbitlyvfyamyris biossance launches in sephora canada storesemeryville calif july   globe newswire  biossance™ the consumer beauty brand from amyris inc nasdaqamrs today announced that it will expand to sephora in over  sephora locations across canada in january investorsamyriscomamyris inc ·   · amyris enters into first product development and production agreement with royal dsm for food and nutrition molecule httpbitlyubwqamyris enters into first product development and production agreement with royal dsm for food and nutrition moleculeemeryville calif july   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announces that it has entered into its first product development and production agreement with koninklijke dsminvestorsamyriscomamyris inc ·  · amyris announces reverse stock split  delivering on strong product revenue growth and execution httpbitlyrnkitamyris announces reverse stock split  delivering on strong product revenue growth and executionemeryville calif june   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it will effect a reverse stock split previously approved by the companys stockholders at its ainvestorsamyriscomamyris inc ·  · amyris exceeds previous debt reduction goal of  million —  million in debt retired httpbitlyqhmyuamyris exceeds previous debt reduction goal of  million —  million in debt retiredemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced it has already exceeded the debt reduction goal the company stated in its may   announcements rinvestorsamyriscomamyris inc ·  · amyris announces closing of first tranche of up to  million in equity financing conversion of debt to equity httpbitlyqbadamyris announces closing of first tranche of up to  million in equity financing and conversion of over  million of debt to equityemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced the closing of the first tranche of up to  million in planned equity financing that the company prinvestorsamyriscomamyris inc ·  · amyris ontrack to double revenue for vitamin e partnership with nenter exclusive vitamin a license with dsm httpbitlyqgcqmamyris ontrack to double revenue for vitamin e partnership with nenter  announces exclusive vitamin a license with royal dsmemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it expects revenue related to its vitamin e partnership with nenter to more than double based investorsamyriscomamyris inc ·  · amyris announces agreements for up to  million in equity financing inprocess initiative to reduce debt httpbitlyptjukfamyris announces agreements for up to  million in equity financing and inprocess initiative to significantly reduce debtemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced a series of agreements for up to  million in equity financing via a registered direct offering of investorsamyriscomamyris inc ·  · royal dsm to make equity investment in amyris with the purpose of establishing a longterm relationship httpbitlyqgyoybroyal dsm to make equity investment in amyris with the purpose of establishing a longterm relationshipheerlen netherlands and emeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company and koninklijke dsm nv royal dsm aexdsmas the global sciinvestorsamyriscomamyris inc ·  · amyris announces much better than expected sales of farnesene to meet accelerated demand by global tire brands httpbitlyqcczzamyris announces much better than expected sales of farnesene to meet accelerated demand for liquid farnesene rubber by global tire brandsemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that its partners success in developing high performance liquid farnesene rubber lfr for use in wiinvestorsamyriscomamyris inc ·  · amyris announces key advancements under darpa multiyear technology investment agreement httpbitlyputhfamyris announces key advancements under darpa multiyear technology investment agreement — enables development of industrialscale fermentation process for virtually any biological moleculeemeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it has successfully expanded its worldclass expertise in strain engineering and optimization investorsamyriscomamyris inc ·  · amyris announces industrial production of leading healthy sweetener product in  httpbitlyqortohamyris announces industrial production of leading healthy sweetener product in emeryville calif may   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it has made significant progress in the development of its healthy sweetener product technology investorsamyriscomamyris inc ·  · amyris agrees to exclusive china manufacturing with blue california httpbitlyorkqavamyris agrees to exclusive china manufacturing with blue california enabling continued record product revenue growth into asian marketsemeryville calif april   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announced that it has expanded the scope of its relationship with phyto tech corp dbainvestorsamyriscomamyris inc ·  · amyriss biossance delivers record firstquarter sales —  eye product at sephora httpbitlyoapkamyriss biossance delivers record firstquarter sales —  eye product at sephora and on track for much better than expected emeryville calif april   globe newswire  amyris inc nasdaqamrs the industrial bioscience company achieved record firstquarter product sales for its biossance brand which is delivering highgrowth and is expecteinvestorsamyriscom amyris inc enters into first product development and production agreement with royal dsm for food and nutrition molecule employer login post jobs job seeker login sign up search life sciences jobs search job title only radius miles km  news  news by subject  news by disease   news by date  search news get our freeindustry enewsletter email       amyris inc enters into first product development and production agreement with royal dsm for food and nutrition molecule tweet   am   life sciences jobs     bullet newest jobs  last  hours   bullet california jobs   bullet massachusetts jobs   bullet new jersey jobs   bullet maryland jobs   bullet washington jobs   view more jobs emeryville calif july   globe newswire  amyris inc nasdaqamrs the industrial bioscience company today announces that it has entered into its first product development and production agreement with koninklijke dsm nv royal dsm aexdsmas the global sciencebased company active in health nutrition and materials to develop a food and nutrition molecule for which dsm is a major market provider as part of the previously announced equity investment dsm is making into amyris dsm and amyris have agreed to focus on a number of short to mediumterm product development  production opportunities in vitamins and other nutritional ingredients this agreement is the first of what is expected to be several of such development and production projects as part of the agreement dsm will partner with amyris and fund the development of the technology to produce the specific molecule that amyris will scale and supply long term to deliver improved performance while growing its business dsm will take the molecule to market utilizing its channel and market access and take advantage of amyris’s biotechnology production which provides a lower cost of production than currently available we are very excited to partner with dsm on our first product development and production agreement said john melo amyris president  ceo this is the first of what are expected to be several highly disruptive products addressing major markets where together we can leverage amyris’s technology platform to reduce cost for products dsm then takes to market in a costadvantaged position about amyris amyris is the integrated renewable products company that is enabling the worlds leading brands to achieve sustainable growth amyris applies its innovative bioscience solutions to convert plant sugars into hydrocarbon molecules and produce specialty ingredients and consumer products the company is delivering its no compromise® products across a number of markets including specialty and performance chemicals flavors and fragrances cosmetics ingredients pharmaceuticals and nutraceuticals more information about the company is available at wwwamyriscom forwardlooking statements this release contains forwardlooking statements regarding amyris and any statements regarding amyris other than statements of historical facts could be deemed to be forwardlooking statements these forwardlooking statements include among other things statements regarding future events such as expected future development and production projects between amyris and dsm amyris’s anticipated cost of production for the molecule subject to the current development and production agreement with dsm and amyris’s expected future performance and business growth that involve risks and uncertainties these statements are based on managements current expectations and actual results and future events may differ materially due to risks and uncertainties including risks related to manufacturing capacity at amyriss brotas facility delays or failures in development production and commercialization of products liquidity and ability to fund capital expenditures amyriss reliance on third parties to achieve its goals and other risks detailed in the risk factors section of amyriss quarterly report on form q filed on may   amyris disclaims any obligation to update information contained in these forwardlooking statements whether as a result of new information future events or otherwise amyris the amyris logo and no compromise are registered trademarks of amyris inc all other trademarks are trademarks of their respective owners contact peter denardo director investor relations and corporate communications amyris inc    investoramyriscom pramyriscom read at biospacecom related news gen and amyris inc announce supply agreement for synthetic dna bay areas oncomed omed tanks some more as glaxosmithkline gsk walks away from rd pact amyris inc creates program to reduce the cost and increase access to leading malaria treatment biotech bestie celgene celg takes stake inks  billion deal with beigene bgne amyris inc announces offering of  million of convertible senior notes due  how transformative is this licensing deal for beigene bgne royal dsm invites entrepreneurs to participate in a unique innovation  partnering conference the  biotechs that could make celgene celg even richer royal dsm publishes  integrated annual report biospace dhx partners with bio business solutions to offer cost savings to bio members please enable javascript to view the comments powered by disqus comments powered by disqus • biospacecom • amyris inc • royal dsm   • biotechpharma  alliances                 products » amyris      about our story management board of directors innovate with us products health  nutrition personal care industrial news press releases blog investors overview press releases corporate governance financial information stock information careers contact us news fragrances news june   nutraceuticals news june   biopharma news june   malaria treatment news june   flavors news june   cosmetics news june   isoprene news may   polymers news may   solvents news may   page  of » stay up to date with our news sign up powered by amyris stay up to date sign up about our story management board of directors innovate with us products health  nutrition personal care industrial news press releases blog investors overview press releases corporate governance financial information stock information careers contact us recent tweets amyris to announce second quarter  financial results on thursday august   httpstcopdlmdyyscyesterdayamyris biossance launches in sephora canada stores httpstcoooiabz days ago copyright amyris  all rights reserved     privacy policy